miércoles, 25 de febrero de 2026

Novo Nordisk strikes deal with U.S. startup to develop oral obesity, diabetes drugs Vivtex was co-founded by renowned MIT professor Robert Langer and others

https://www.statnews.com/2026/02/25/novo-nordisk-vivtex-langer-obesity-diabetes/ By Jonathan Saltzman — Boston GlobeFeb. 25, 2026

No hay comentarios: